Your browser doesn't support javascript.
loading
Alzheimer's-Causing Mutations Shift Aß Length by Destabilizing γ-Secretase-Aßn Interactions.
Szaruga, Maria; Munteanu, Bogdan; Lismont, Sam; Veugelen, Sarah; Horré, Katrien; Mercken, Marc; Saido, Takaomi C; Ryan, Natalie S; De Vos, Tatjana; Savvides, Savvas N; Gallardo, Rodrigo; Schymkowitz, Joost; Rousseau, Frederic; Fox, Nick C; Hopf, Carsten; De Strooper, Bart; Chávez-Gutiérrez, Lucía.
Afiliação
  • Szaruga M; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium.
  • Munteanu B; Center of Applied Research in Biomedical Mass Spectrometry, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.
  • Lismont S; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium.
  • Veugelen S; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium.
  • Horré K; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium.
  • Mercken M; Janssen Research & Development, Division of Janssen Pharmaceutica NV, 2340 Beerse, Belgium.
  • Saido TC; Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Hirosawa Wako City, Saitama 351-0198, Japan.
  • Ryan NS; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square, WC1N 3BG London, UK.
  • De Vos T; Ghent University, Laboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, 9000 Ghent, Belgium; Center for Inflammation Research, VIB-UGent Technologiepark 927, 9052 Ghent, Belgium.
  • Savvides SN; Ghent University, Laboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, 9000 Ghent, Belgium; Center for Inflammation Research, VIB-UGent Technologiepark 927, 9052 Ghent, Belgium.
  • Gallardo R; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, University of Leuven, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Schymkowitz J; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, University of Leuven, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Rousseau F; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Cellular and Molecular Medicine, University of Leuven, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square, WC1N 3BG London, UK.
  • Hopf C; Center of Applied Research in Biomedical Mass Spectrometry, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.
  • De Strooper B; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium; Dementia Research Institute UK, University College London, Queen Square, WC1N 3BG London, UK. Electronic addr
  • Chávez-Gutiérrez L; KU Leuven-VIB Center for Brain & Disease Research, VIB, 3000 Leuven, Belgium; Department of Neurosciences, Leuven Institute for Neuroscience and Disease, KU Leuven, 3000 Leuven, Belgium. Electronic address: Lucia.ChavezGutierrez@cme.vib-kuleuven.be.
Cell ; 170(3): 443-456.e14, 2017 Jul 27.
Article em En | MEDLINE | ID: mdl-28753424
Alzheimer's disease (AD)-linked mutations in Presenilins (PSEN) and the amyloid precursor protein (APP) lead to production of longer amyloidogenic Aß peptides. The shift in Aß length is fundamental to the disease; however, the underlying mechanism remains elusive. Here, we show that substrate shortening progressively destabilizes the consecutive enzyme-substrate (E-S) complexes that characterize the sequential γ-secretase processing of APP. Remarkably, pathogenic PSEN or APP mutations further destabilize labile E-S complexes and thereby promote generation of longer Aß peptides. Similarly, destabilization of wild-type E-S complexes by temperature, compounds, or detergent promotes release of amyloidogenic Aß. In contrast, E-Aßn stabilizers increase γ-secretase processivity. Our work presents a unifying model for how PSEN or APP mutations enhance amyloidogenic Aß production, suggests that environmental factors may increase AD risk, and provides the theoretical basis for the development of γ-secretase/substrate stabilizing compounds for the prevention of AD.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeo Hidrolases / Precursor de Proteína beta-Amiloide / Presenilina-1 / Doença de Alzheimer / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Peptídeo Hidrolases / Precursor de Proteína beta-Amiloide / Presenilina-1 / Doença de Alzheimer / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica